Webinar: Flexible & Scalable Genetic Screens for Novel Therapeutic Target Discovery: An Overview of Noteworthy Case Studies

Date: Thursday, January 20, 2022

Time: 10:00 am - 11:00 am USA Pacific Time (PT); 

1:00 pm - 2:00 pm USA Eastern Time (ET); 19:00 h - 20:00 h CEST

Speaker: 

Paul Diehl, Ph.D., Chief Operating Officer, Cellecta Inc. 

Abstract

Measurements of changes in gene activation and expression provide a basis to understand genetic changes causing biological responses. Cell-to-cell gene disruption induced by CRISPR and other gene-perturbation technologies help tease out the drivers of these responses. Adaptations of these two screening approaches can be used to discover the genetic drivers responsible for phenotypic variabilities such as drug sensitivities and disease variation across tissue microenvironments, and between single cells. An overview of recent publications illustrating successful use of these methods will be presented.

A brief overview of Cellecta technologies will precede the presentation

Webinar highlights

Get an overview of recent peer-reviewed publications demonstrating how functional CRISPR screening and other related methods have been used to identify:

  • genes modulating drug response
  • genes responsible for drug resistance
  • possible mechanisms of action of drugs
Register Now
Please email info@cellecta.com with any comments.


Also in Events, Conferences, Meetings

Association for Molecular Pathology Annual Meeting & Expo 2024

November 19 - 23, 2024
Read More
Society for Immunotherapy of Cancer Annual Meeting 2024

November 6 - 10, 2024
Read More
Immuno US 2024

October 28 - 29, 2024
Read More